Skip to main content

Sleepless? You may want to address this problem soonest. The reason is that a new Canadian study has found that older people who suffer from insomnia are at greater risk of developing memory decline and long-term cognitive impairment such as dementia.  Postdoc Nathan Cross says a huge longitudinal study shows that psychological disorder is an important comorbidity for dementia and other cognitive impairments.

Sleep quality counts

The study, published in the journal SLEEP, is based on data from more than 26,000 participants of the Canadian Longitudinal Study on Aging, all aged between 45 and 85. The researchers compared completed self-reported evaluations of sleep, memory, and neuropsychological testing in several cognitive domains from 2019 to a follow-up in 2022. Participants who reported worsening sleep quality in that three-year interval also had greater odds of reporting subjective memory decline.

“We found that insomnia specifically was related to worse memory performance compared to those who have some insomnia symptoms alone or no sleep problems at all,” says the study’s co-lead author Nathan Cross, a postdoctoral fellow at the Sleep, Cognition and Neuroimaging Lab. “This deficit in memory was specific, as we also looked at other cognitive function domains such as attention span multi-tasking. We only found differences in memory.” 

Big data and a sharp focus 

Jean-Louis Zhao at the Université de Montréal was the study’s co-lead. Lisa Kakinami and Thanh Dang-Vu from the PERFORM Centre contributed to the study, as did Chun Yao and Ronald Postuma from McGill University and Julie Carrier and Nadia Gosselin at UdeM.

Jean-Louis Zhao and Nathan Cross: “Adequately treating insomnia disorder might become an important preventive measure for cognitive decline.”

Sleeplessness, sleep disorders and sleep quality

Unlike previous studies on sleep quality, Cross says, this one benefits from its very large data set and its focus on sleep disorders.

Insomnia, he points out, has been classified as a psychological disorder in the Diagnostic and Statistical Manual of Mental Disorders, the primary reference handbook used by physicians worldwide.

Insomnia is not just tossing and turning for a time before bed: “A diagnosis requires symptoms of difficulty falling asleep, staying asleep or waking too early three nights a week over a period of three months. Additionally, those with insomnia must report that this sleepless problem causes them difficulty in the daytime,” Cross explains. 

sleepless

tommaso79/shutterstock

Study methodology

For this study, the researchers grouped their subjects into one of three categories: those who reported no sleep problems at the 2019 baseline, those who had some insomnia symptoms, and those who developed probable insomnia.

Older men who sleep badly are at greater risk

When they looked at the data from the 2022 follow-up, those who had reported they sleep badly, or had a worsening sleep quality — from no symptoms to some or probable insomnia, or from some symptoms to probable insomnia — were more likely to report memory decline or have it diagnosed by their physician. They were also more likely to show a higher prevalence of anxiety, depression, daytime sleepiness, breathing interruptions during sleep, other sleep-related issues, smoking, and a greater body mass index (BMI) score. All of these are considered risk factors for cognitive decline and dementia.

Additionally, the study found that sleepless men with insomnia perform worse on memory tests than women. This suggests that older men may be at greater risk.

“However, there is some good news: sleep disorders like insomnia can be treated,” Cross adds. “This highlights the importance of properly diagnosing and managing insomnia as early as possible in older adults. Adequately treating insomnia disorder might become an important preventive measure for cognitive decline and mitigate the incidence of dementia in later life.” 

References

The Canadian Longitudinal Study on Aging is funded by the Canadian Institutes of Health Research and the Canada Foundation for Innovation, as well as the provinces of Newfound and Labrador, Nova Scotia, Quebec, Ontario, Manitoba, Alberta and British Columbia.  

Read the cited paper: “Insomnia disorder increases the risk of subjective memory decline in middle-aged and older adults: a longitudinal analysis of the Canadian Longitudinal Study on Aging.”  

Em Sloane

Em Sloane

I am an introverted nature lover, and long time contributor to LongevityLive.com. My role is to publish the information in a consumer friendly format, which we receive on the latest medical news, press releases and general information on the latest longevity related research findings.

Longevity Live is a digital publisher AND DOES NOT OFFER PERSONAL HEALTH OR MEDICAL ADVICE. IF YOU’RE FACING A MEDICAL EMERGENCY, CALL YOUR LOCAL EMERGENCY SERVICES IMMEDIATELY, OR VISIT THE NEAREST EMERGENCY ROOM OR URGENT CARE CENTER. YOU SHOULD CONSULT YOUR HEALTHCARE PROVIDER BEFORE STARTING ANY NUTRITION, DIET, EXERCISE, FITNESS, MEDICAL, OR WELLNESS PROGRAM.

This content, developed through collaboration with licensed medical professionals and external contributors, including text, graphics, images, and other material contained on the website, apps, newsletter, and products (“Content”), is general in nature and for informational purposes only and does not constitute medical advice; the Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.

Longevity Live makes no guarantees about the efficacy or safety of products or treatments described in any of our posts. Any information on supplements, related services and drug information contained in our posts are subject to change and are not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.

Longevity does not recommend or endorse any specific test, clinician, clinical care provider, product, procedure, opinion, service, or other information that may be mentioned on Longevity’s websites, apps, and Content.